AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aarti Pharmalabs Ltd has announced that its Nomination and Remuneration Committee approved the grant of 57,600 stock options to eligible employees of the company and its subsidiary. The options are granted under the APL Performance Stock Option Plan 2023 (PSOP 2023) at an exercise price of Rs. 5 per option. This disclosure is made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The grant is subject to SEBI's Share Based Employee Benefits and Sweat Equity Regulations, 2021. This is a routine employee compensation disclosure that does not require shareholder approval at this stage.
This is a standard ESOP grant announcement with a nominal exercise price, which is positive for employee retention but has minimal direct impact on stock price. The dilution is negligible at 57,600 options.